Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study
Conclusion Rituximab was proven an effective and safe treatment option for adult FR/SDNS patients with MCD or FSGS in maintaining disease remission and minimizing corticosteroid exposure.PMID:37963441 | DOI:10.1159/000535010
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Lan Lan Yuxin Lin Binfeng Yu Yin Wang Hong Pan Huijing Wang Xiaowei Lou Xiabing Lang Qiankun Zhang Lie Jin Yi Yang Liang Xiao Jianghua Chen Fei Han Source Type: research
More News: China Health | Corticosteroid Therapy | Nephrotic Syndrome | Pediatrics | Rituxan | Study | Urology & Nephrology